Literature DB >> 35074846

How I Treat Complement-Mediated TMA.

C John Sperati1.   

Abstract

Entities:  

Keywords:  complement; glomerulonephritis; hemolytic uremic syndrome

Mesh：

Substances：

Year:  2022        PMID： 35074846      PMCID： PMC8975032          DOI： 10.2215/CJN.13581021

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Complement Activation and Thrombotic Microangiopathies.

Authors:  Marta Palomo; Miquel Blasco; Patricia Molina; Miquel Lozano; Manuel Praga; Sergi Torramade-Moix; Julia Martinez-Sanchez; Joan Cid; Gines Escolar; Enric Carreras; Cristina Paules; Fatima Crispi; Luis F Quintana; Esteban Poch; Lida Rodas; Emma Goma; Johann Morelle; Mario Espinosa; Enrique Morales; Ana Avila; Virginia Cabello; Gema Ariceta; Sara Chocron; Joaquin Manrique; Xoana Barros; Nadia Martin; Ana Huerta; Gloria M Fraga-Rodriguez; Mercedes Cao; Marisa Martin; Ana Maria Romera; Francesc Moreso; Anna Manonelles; Eduard Gratacos; Arturo Pereira; Josep M Campistol; Maribel Diaz-Ricart
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-06       Impact factor: 8.237

2.  Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta-analysis.

Authors:  Koosha Paydary; Emma Banwell; Jiayi Tong; Yong Chen; Adam Cuker
Journal:  Transfusion       Date:  2020-08-05       Impact factor: 3.157

Review 3.  Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2021-05-05       Impact factor: 28.314

4.  Etiology and Outcomes of Thrombotic Microangiopathies.

Authors:  Guillaume Bayer; Florent von Tokarski; Benjamin Thoreau; Adeline Bauvois; Christelle Barbet; Sylvie Cloarec; Elodie Mérieau; Sébastien Lachot; Denis Garot; Louis Bernard; Emmanuel Gyan; Franck Perrotin; Claire Pouplard; François Maillot; Philippe Gatault; Bénédicte Sautenet; Emmanuel Rusch; Matthias Buchler; Cécile Vigneau; Fadi Fakhouri; Jean-Michel Halimi
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-12       Impact factor: 8.237

5.  Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation.

Authors:  Benjamin Thoreau; Florent von Tokarski; Adeline Bauvois; Guillaume Bayer; Christelle Barbet; Sylvie Cloarec; Elodie Mérieau; Sébastien Lachot; Denis Garot; Louis Bernard; Emmanuel Gyan; Franck Perrotin; Claire Pouplard; François Maillot; Philippe Gatault; Bénédicte Sautenet; Emmanuel Rusch; Véronique Frémeaux-Bacchi; Cécile Vigneau; Fadi Fakhouri; Jean-Michel Halimi
Journal:  Clin J Am Soc Nephrol       Date:  2021-09       Impact factor: 10.614

6.  Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study.

Authors:  Christophe Passot; Rebecca Sberro-Soussan; Dominique Bertrand; Sophie Caillard; Betoul Schvartz; Camille Domenger; Cécile Contin-Bordes; Gilles Paintaud; Jean-Michel Halimi; David Ternant; Philippe Gatault
Journal:  Br J Clin Pharmacol       Date:  2020-12-07       Impact factor: 4.335

7.  Ex vivo assays to detect complement activation in complementopathies.

Authors:  Xuan Yuan; Jia Yu; Gloria Gerber; Shruti Chaturvedi; Michael Cole; Hang Chen; Ara Metjian; C John Sperati; Evan M Braunstein; Robert A Brodsky
Journal:  Clin Immunol       Date:  2020-10-24       Impact factor: 3.969

8.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Timothy H J Goodship; H Terence Cook; Fadi Fakhouri; Fernando C Fervenza; Véronique Frémeaux-Bacchi; David Kavanagh; Carla M Nester; Marina Noris; Matthew C Pickering; Santiago Rodríguez de Córdoba; Lubka T Roumenina; Sanjeev Sethi; Richard J H Smith
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612

9.  Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Authors:  Jan Menne; Yahsou Delmas; Fadi Fakhouri; Christoph Licht; Åsa Lommelé; Enrico E Minetti; François Provôt; Eric Rondeau; Neil S Sheerin; Jimmy Wang; Laurent E Weekers; Larry A Greenbaum
Journal:  BMC Nephrol       Date:  2019-04-10       Impact factor: 2.388

Review 10.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Tim H Goodship; Anna Richards
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.